Harrys Torres
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Harrys Torres
May 22, 2024, 14:19 |
Insight
Harrys Torres: Is Universal HepC Screening Feasible in Cancer Centers?
Harrys Torres, Professor, Founding Director of Hepatitis C Clinic at MD Anderson Cancer Center, shared on…
Feb 8, 2024, 05:23 |
Blog
Khalis Mustafayev: Our recent article, co-authored with Dr. Vincent Mallet and Dr. Harrys Torres is now published in the Journal of Immunotherapy and Precision Oncology
Khalis Mustafayev, Postdoctoral FellowPostdoctoral Fellow at MD Anderson Cancer Center, recently shared on LinkedIn: "Exciting…
All:
2
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube